Andoh Akira, Kobayashi Toshio, Kuzuoka Hiroyuki, Tsujikawa Tomoyuki, Suzuki Yasuo, Hirai Fumihito, Matsui Toshiyuki, Nakamura Shiro, Matsumoto Takayuki, Fujiyama Yoshihide
Division of Mucosal Immunology, Graduate School of Medicine, Shiga University of Medical Science, Otsu, Shiga 520-2192, Japan.
Miyagi University, Sendai, Miyagi 982-0215, Japan.
Biomed Rep. 2014 May;2(3):370-373. doi: 10.3892/br.2014.252. Epub 2014 Mar 14.
The gut microbiota plays a significant role in the pathogenesis of Crohn's disease (CD). In this study, we analyzed the disease activity and associated fecal microbiota profiles in 160 CD patients and 121 healthy individuals. Fecal samples from the CD patients were collected during three different clinical phases, the active (n=66), remission-achieved (n=51) and remission-maintained (n=43) phases. Terminal restriction fragment length polymorphism (T-RFLP) and data mining analysis using the Classification and Regression Tree (C&RT) approach were performed. Data mining provided a decision tree that clearly identified the various subject groups (nodes). The majority of the healthy individuals were divided into Node-5 and Node-8. Healthy subjects comprised 99% of Node-5 (91 of 92) and 84% of Node-8 (21 of 25 subjects). Node-3 was characterized by CD (136 of 160 CD subjects) and was divided into Node-6 and Node-7. Node-6 (n=103) was characterized by subjects in the active phase (n=48; 46%) and remission-achieved phase (n=39; 38%) and Node-7 was characterized by the remission-maintained phase (21 of 37 subjects; 57%). Finally, Node-6 was divided into Node-9 and Node-10. Node-9 (n=78) was characterized by subjects in the active phase (n=43; 55%) and Node-10 (n=25) was characterized by subjects in the remission-maintained phase (n=16; 64%). Differences in the gut microbiota associated with disease activity of CD patients were identified. Thus, data mining analysis appears to be an ideal tool for the characterization of the gut microbiota in inflammatory bowel disease.
肠道微生物群在克罗恩病(CD)的发病机制中起着重要作用。在本研究中,我们分析了160例CD患者和121名健康个体的疾病活动情况及相关粪便微生物群谱。CD患者的粪便样本在三个不同临床阶段收集,即活动期(n = 66)、缓解期(n = 51)和维持缓解期(n = 43)。进行了末端限制性片段长度多态性(T-RFLP)分析以及使用分类回归树(C&RT)方法的数据挖掘分析。数据挖掘提供了一个决策树,该决策树清晰地识别出了不同的受试者组(节点)。大多数健康个体被分为节点5和节点8。健康受试者占节点5的99%(92人中的91人)和节点8的84%(25名受试者中的21人)。节点3以CD患者为特征(160例CD受试者中的136人),并被分为节点6和节点7。节点6(n = 103)以活动期(n = 48;46%)和缓解期(n = 39;38%)的受试者为特征,节点7以维持缓解期(37名受试者中的21人;57%)为特征。最后,节点6被分为节点9和节点10。节点9(n = 78)以活动期的受试者为特征(n = 43;55%),节点10(n = 25)以维持缓解期的受试者为特征(n = 16;64%)。确定了与CD患者疾病活动相关的肠道微生物群差异。因此,数据挖掘分析似乎是表征炎症性肠病肠道微生物群的理想工具。